Dr. Moishe Liberman, MD
Claim this profileCHUM
Affiliated Hospitals
CHUM
University Of Montreal
Clinical Trials Moishe Liberman, MD is currently running
STING MARK Fiducial Marker
for Cancer
This trial tests a new device called STING-MARK, which helps doctors mark and locate tumors inside the body using x-rays. The device is tested on organs removed during surgeries or transplants. It aims to improve accuracy in finding tumors for better treatment.
Recruiting
1 award
N/A
Aerosol Glycerine System
for Detecting Lung Air Leaks
Air leaks represent one of the most common complications and postoperative morbidity in thoracic surgery. Air leaks have been associated with the largest preventable morbidity associated with increased costs following lobectomy (typically related to increased length of stay). However, the standard used to detect and localize the air leaks, the submersion test, is not suitable for the standard surgical procedure, Video Assisted Thoracic Surgery. Considering the prevalence of this complication and the absence of a surgical standard of care for such complications, the aim of this study is to develop a system to create and send a glycerine aerosol smoke in the lungs of the patient. The smoke is visible with standard laparoscope and will flow though the pulmonary leak, thereby reducing postoperative surgical complications, morbidity, and length of stay for patients undergoing pulmonary resection.
Recruiting
1 award
N/A
More about Moishe Liberman, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Moishe Liberman, MD has experience with
- Bio-adhesive
- STING MARK Universal Fiducial Marker System
- Chemotherapy
- Metastasectomy
- Placebo
- Nivolumab
Breakdown of trials Moishe Liberman, MD has run
Lung Cancer
Pneumothorax
Non-Small Cell Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Moishe Liberman, MD specialize in?
Moishe Liberman, MD focuses on Lung Cancer and Pneumothorax. In particular, much of their work with Lung Cancer has involved Stage I patients, or patients who are undergoing treatment.
Is Moishe Liberman, MD currently recruiting for clinical trials?
Yes, Moishe Liberman, MD is currently recruiting for 5 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Moishe Liberman, MD has studied deeply?
Yes, Moishe Liberman, MD has studied treatments such as Bio-adhesive, STING MARK Universal Fiducial Marker System, Chemotherapy.
What is the best way to schedule an appointment with Moishe Liberman, MD?
Apply for one of the trials that Moishe Liberman, MD is conducting.
What is the office address of Moishe Liberman, MD?
The office of Moishe Liberman, MD is located at: CHUM, Montréal, Quebec H2X3E4 Canada. This is the address for their practice at the CHUM.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.